Cargando…
Aspartic acid at residue 185 modulates the capacity of HP-PRRSV nsp4 to antagonize IFN-I expression
In a previous study, we have shown that highly-pathogenic PRRSV (HP-PRRSV) nonstructural protein 4 (nsp4) antagonizes type I IFN expression induced by poly(I:C). Here, we demonstrated that the mutation of Aspartic acid 185 (Asp185) impaired the ability of nsp4 to inhibit IFN-I production induced by...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172695/ https://www.ncbi.nlm.nih.gov/pubmed/32452419 http://dx.doi.org/10.1016/j.virol.2020.04.007 |
_version_ | 1783524306335039488 |
---|---|
author | Wei, Ze-yu Liu, Fang Li, Yu Wang, Hong-lei Zhang, Zi-ding Chen, Zhong-zhou Feng, Wen-hai |
author_facet | Wei, Ze-yu Liu, Fang Li, Yu Wang, Hong-lei Zhang, Zi-ding Chen, Zhong-zhou Feng, Wen-hai |
author_sort | Wei, Ze-yu |
collection | PubMed |
description | In a previous study, we have shown that highly-pathogenic PRRSV (HP-PRRSV) nonstructural protein 4 (nsp4) antagonizes type I IFN expression induced by poly(I:C). Here, we demonstrated that the mutation of Aspartic acid 185 (Asp185) impaired the ability of nsp4 to inhibit IFN-I production induced by poly(I:C). Subsequently, we verified that all the mutants at the residue 185, regardless of amino acid size (including Cys and Ser) and charge (including Glu and Lys), impaired nsp4 catalytic activity. However, when Asp185 in nsp4 was replaced by a similar structure amino acid Asparagine 185 (Asn185), nsp4 stayed but with a decreased protease activity. Importantly, the recombinant virus with Asn185 mutation in HP-PRRSV-nsp4 exhibited slower replication rate and higher ability to induce IFN-I expression compared with wild-type (wt) HP-PRRSV. |
format | Online Article Text |
id | pubmed-7172695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71726952020-04-22 Aspartic acid at residue 185 modulates the capacity of HP-PRRSV nsp4 to antagonize IFN-I expression Wei, Ze-yu Liu, Fang Li, Yu Wang, Hong-lei Zhang, Zi-ding Chen, Zhong-zhou Feng, Wen-hai Virology Article In a previous study, we have shown that highly-pathogenic PRRSV (HP-PRRSV) nonstructural protein 4 (nsp4) antagonizes type I IFN expression induced by poly(I:C). Here, we demonstrated that the mutation of Aspartic acid 185 (Asp185) impaired the ability of nsp4 to inhibit IFN-I production induced by poly(I:C). Subsequently, we verified that all the mutants at the residue 185, regardless of amino acid size (including Cys and Ser) and charge (including Glu and Lys), impaired nsp4 catalytic activity. However, when Asp185 in nsp4 was replaced by a similar structure amino acid Asparagine 185 (Asn185), nsp4 stayed but with a decreased protease activity. Importantly, the recombinant virus with Asn185 mutation in HP-PRRSV-nsp4 exhibited slower replication rate and higher ability to induce IFN-I expression compared with wild-type (wt) HP-PRRSV. Elsevier Inc. 2020-07 2020-04-21 /pmc/articles/PMC7172695/ /pubmed/32452419 http://dx.doi.org/10.1016/j.virol.2020.04.007 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Wei, Ze-yu Liu, Fang Li, Yu Wang, Hong-lei Zhang, Zi-ding Chen, Zhong-zhou Feng, Wen-hai Aspartic acid at residue 185 modulates the capacity of HP-PRRSV nsp4 to antagonize IFN-I expression |
title | Aspartic acid at residue 185 modulates the capacity of HP-PRRSV nsp4 to antagonize IFN-I expression |
title_full | Aspartic acid at residue 185 modulates the capacity of HP-PRRSV nsp4 to antagonize IFN-I expression |
title_fullStr | Aspartic acid at residue 185 modulates the capacity of HP-PRRSV nsp4 to antagonize IFN-I expression |
title_full_unstemmed | Aspartic acid at residue 185 modulates the capacity of HP-PRRSV nsp4 to antagonize IFN-I expression |
title_short | Aspartic acid at residue 185 modulates the capacity of HP-PRRSV nsp4 to antagonize IFN-I expression |
title_sort | aspartic acid at residue 185 modulates the capacity of hp-prrsv nsp4 to antagonize ifn-i expression |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172695/ https://www.ncbi.nlm.nih.gov/pubmed/32452419 http://dx.doi.org/10.1016/j.virol.2020.04.007 |
work_keys_str_mv | AT weizeyu asparticacidatresidue185modulatesthecapacityofhpprrsvnsp4toantagonizeifniexpression AT liufang asparticacidatresidue185modulatesthecapacityofhpprrsvnsp4toantagonizeifniexpression AT liyu asparticacidatresidue185modulatesthecapacityofhpprrsvnsp4toantagonizeifniexpression AT wanghonglei asparticacidatresidue185modulatesthecapacityofhpprrsvnsp4toantagonizeifniexpression AT zhangziding asparticacidatresidue185modulatesthecapacityofhpprrsvnsp4toantagonizeifniexpression AT chenzhongzhou asparticacidatresidue185modulatesthecapacityofhpprrsvnsp4toantagonizeifniexpression AT fengwenhai asparticacidatresidue185modulatesthecapacityofhpprrsvnsp4toantagonizeifniexpression |